Principal Investigator
Janaki Sharma
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20240308
Clinical Trial Summary
An Open-label, Multicenter Phase 1b Study of the Safety, Tolerability, and Pharmacokinetic /Pharmacodynamic Profile of the ATR Inhibitor M1774 in combination with DNA Damage Response
Inhibitors or Immune Checkpoint Inhibitors in Patients with Metastatic or Locally Advanced Unresectable Solid Tumors
Phase
Phase I
Funding Agency/Sponsor
Industrial
Disease
Prostate, Bladder, and Kidney Cancers
Contact Information
Phone Number
+1 (954) 8177628